Subscribe to RSS

DOI: 10.1055/s-0044-1800930
A Comparative Study of Cancer and Blood Sugar Levels Among Adults as Per NFHS- 4 and NFHS- 5 Surveys in India

Abstract
The comparison between the current state of these lifestyle disorders and the prevalence of adult lifestyle diseases including diabetes and cancer in India, as reported by NFHS-4 and NFHS-5. Cancer is still the second greatest cause of death worldwide, despite recent advancements in technology and medicine. Northeast India has a greater cancer burden than the rest of the nation, according to a 2020 study released by the Indian National Cancer Registry. In India, an estimated 77 million individuals had diabetes in 2019, and by 2045, that number is expected to rise to over 134 million Program. In accordance with the 2020 WHO study, India had a 30% higher number of cancer-related fatalities (850,000 versus 610,000 deaths) while only reporting 1.32 million new instances of the disease, compared with 2.28 million in the United States of America. In the globe, cancer of the breast is among the most common carcinomas in women to be diagnosed, and it also ranks top in terms of cancer-related deaths. Around the world, the prevalence of cancer of the breast is steadily rising. The primary focus of this study is the high incidence of lifestyle illnesses in the adult Indian population, as measured by NFHS-4 and NFHS-5, including diabetes and cancer. Based on data from the NFHS-4 and NFHS-5 Survey, we discovered that there are growing trends in the percentage of mouth cancer among males (both urban and rural), whereas there are declining trends in the percentage of cervical, oral, and breast cancer in the case of women.
Author's Contribution
Amandeep Kaur wrote the main manuscript, Ranjeet Kumar contributed to the study design and reviewed the final manuscript, Sonakshi Garg and Hardik Kumar contributed to data collection, and Dharmendra Kumar reviewed the final manuscript.
Publication History
Received: 12 July 2024
Accepted: 24 October 2024
Article published online:
18 December 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Kristina SA, Endarti D, Aditama H. “Global cancer-facts & figures 4th edition,” Am Cancer Soc, vol. 29, pp. 138–144, 2018.
- 2 Ferlay J. et al. “Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020. ” Cancer Tomorrow, 2021.
- 3 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
- 4 Zhang S-Z, Xie L, Shang Z-J. Burden of oral cancer on the 10 most populous countries from 1990 to 2019: estimates from the global burden of disease study 2019. Int J Environ Res Public Health 2022; 19 (02) 875
- 5 Zheng R, Wang S, Zhang S. et al. Global, regional, and national lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing) 2023; 68 (21) 2620-2628
- 6 Tripathi N, Kadam YR, Dhobale RV, Gore AD. Barriers for early detection of cancer amongst Indian rural women. South Asian J Cancer 2014; 3 (02) 122-127
- 7 Chintapally N, Nuwayhid M, Arroju V. et al. State of cancer care in India and opportunities for innovation. Future Oncol 2023; 19 (39) 2593-2606
- 8 Mathur P, Sathishkumar K, Chaturvedi M. et al; ICMR-NCDIR-NCRP Investigator Group. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Glob Oncol 2020; 6: 1063-1075
- 9 Pongener M. The Conundrum of the Cancer Burden and Disparity in Cancer Care Delivery in Northeast India, with Special Reference to Nagaland. Indian J Med Paediatr Oncol 2024; 45 (03) 266-270
- 10 Finke I, Behrens G, Weisser L, Brenner H, Jansen L. Socioeconomic differences and lung cancer survival—systematic review and meta-analysis. Front Oncol 2018; 8: 536
- 11 Williams J, Allen L, Wickramasinghe K, Mikkelsen B, Roberts N, Townsend N. A systematic review of associations between non-communicable diseases and socioeconomic status within low- and lower-middle-income countries. J Glob Health 2018; 8 (02) 020409
- 12 Hull R, Mbele M, Makhafola T. et al. Cervical cancer in low and middle-income countries. Oncol Lett 2020; 20 (03) 2058-2074
- 13 Arafah M, Rashid S, Tulbah A, Akhtar M. Carcinomas of the uterine cervix: comprehensive review with an update on pathogenesis, nomenclature of precursor and invasive lesions, and differential diagnostic considerations. Adv Anat Pathol 2021; 28 (03) 150-170
- 14 Howard A, Agrawal N, Gooi Z. Lip and oral cavity squamous cell carcinoma. Hematol Oncol Clin North Am 2021; 35 (05) 895-911
- 15 Tirelli G, Uderzo F, Gardenal N, Boscolo-Rizzo P, Marcuzzo AV. Lymph nodes of the perimandibular area: from anatomical classification to pathological role in cancer of oral cavity, oropharynx and skin. J Cancer Metastasis Treat 2023; 9: 20
- 16 Ferlay J, Colombet M, Soerjomataram I. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144 (08) 1941-1953
- 17 Rahman QB, Iocca O, Kufta K, Shanti RM. Global burden of head and neck cancer. Oral Maxillofac Surg Clin North Am 2020; 32 (03) 367-375
- 18 AlSamhori JF. et al. J Med Surg Public Health 2024
- 19 Smolarz B, Nowak AZ, Romanowicz H. Breast cancer—epidemiology, classification, pathogenesis and treatment (review of literature). Cancers (Basel) 2022; 14 (10) 2569
- 20 Tu H, Zhou X, Zhou H. et al. Anti-tumor effect and mechanisms of Timosaponin AIII across diverse cancer progression. Biochem Pharmacol 2024; 228: 116080
- 21 Wu T, Duan Y, Zhang T, Tian W, Liu H, Deng Y. Research trends in the application of artificial intelligence in oncology: A bibliometric and network visualization study. Front Biosci (Landmark Ed) 2022; 27 (09) 254
- 22 Kaur A, Kumar R, Sharma A. Prevalence of Diabetes, Hypertension, and Obesity in Punjab: A Comparison between NFHS-4 and NFHS-5 Surveys. Curr Diabetes Rev 2024
- 23 Dayal D, Gupta BM, Raviteja KV, Pal R, Dhawan SM. Research on type 2 diabetes in India during 1982 to 2019: a comprehensive bibliometric assessment. J. Diabetol. 2021; 12 (04) 472-479
- 24 Ranjani H, Mohan V. Prevention and control of noncommunicable diseases role of family physicians in improving compliance to lifestyle modification. Asian J. Diabetol. 2009; 11 (02) 9-14
- 25 Verma N, Rastogi S, Chia YC. et al. Non-pharmacological management of hypertension. J Clin Hypertens (Greenwich) 2021; 23 (07) 1275-1283